108 related articles for article (PubMed ID: 15736455)
1. Correlation between the histological grade of chondrosarcoma and the expression of MMPs, ADAMTSs and TIMPs.
Sugita H; Osaka S; Toriyama M; Osaka E; Yoshida Y; Ryu J; Sano M; Sugitani M; Nemoto N
Anticancer Res; 2004; 24(6):4079-84. PubMed ID: 15736455
[TBL] [Abstract][Full Text] [Related]
2. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Kawashima A; Okada Y; Nakanishi I; Ueda Y; Iwata K; Roessner A
Gen Diagn Pathol; 1997 Feb; 142(3-4):129-37. PubMed ID: 9065576
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
6. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
7. TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2.
Wang WM; Ge G; Lim NH; Nagase H; Greenspan DS
Biochem J; 2006 Sep; 398(3):515-9. PubMed ID: 16771712
[TBL] [Abstract][Full Text] [Related]
8. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in giant cell tumor of bone: an immunohistochemical study with clinical correlation.
Schoedel KE; Greco MA; Stetler-Stevenson WG; Ohori NP; Goswami S; Present D; Steiner GC
Hum Pathol; 1996 Nov; 27(11):1144-8. PubMed ID: 8912822
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Söderström M; Aro HT; Ahonen M; Johansson N; Aho A; Ekfors T; Böhling T; Kähäri VM; Vuorio E
APMIS; 2001 Apr; 109(4):305-15. PubMed ID: 11469503
[TBL] [Abstract][Full Text] [Related]
10. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc.
Le Maitre CL; Freemont AJ; Hoyland JA
J Pathol; 2004 Sep; 204(1):47-54. PubMed ID: 15307137
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
Cui Y; Yu J; Urban JP; Young DA
Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
[TBL] [Abstract][Full Text] [Related]
13. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
Lichtinghagen R; Musholt PB; Stephan C; Lein M; Kristiansen G; Hauptmann S; Rudolph B; Schnorr D; Loening SA; Jung K
Anticancer Res; 2003; 23(3B):2617-24. PubMed ID: 12894549
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
15. Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.
Held-Feindt J; Paredes EB; Blömer U; Seidenbecher C; Stark AM; Mehdorn HM; Mentlein R
Int J Cancer; 2006 Jan; 118(1):55-61. PubMed ID: 16003758
[TBL] [Abstract][Full Text] [Related]
16. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
17. Regulated expression of ADAMTS family members in follicles and cumulus oocyte complexes: evidence for specific and redundant patterns during ovulation.
Richards JS; Hernandez-Gonzalez I; Gonzalez-Robayna I; Teuling E; Lo Y; Boerboom D; Falender AE; Doyle KH; LeBaron RG; Thompson V; Sandy JD
Biol Reprod; 2005 May; 72(5):1241-55. PubMed ID: 15659705
[TBL] [Abstract][Full Text] [Related]
18. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm].
Wan Y; Wei Q; Pan Y; Liu Y
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):510-3. PubMed ID: 11832095
[TBL] [Abstract][Full Text] [Related]
19. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
Berend KR; Toth AP; Harrelson JM; Layfield LJ; Hey LA; Scully SP
J Bone Joint Surg Am; 1998 Jan; 80(1):11-7. PubMed ID: 9469303
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
